Pascal and Francis Bibliographic Databases


Search results

Your search

ct.\*:("Blood coagulation")


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 45622

  • Page / 1825

Selection :

  • and

Determination of plasma aprotinin levels by functional and immunologic assaysCARDIGAN, R. A; MACKIE, I. J; GIPPNER-STEPPERT, C et al.Blood coagulation & fibrinolysis. 2001, Vol 12, Num 1, pp 37-42, issn 0957-5235Article

Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparinBATES, Shannon M; WEITZ, Jeffrey I; JOHNSTON, Marilyn et al.Archives of internal medicine (1960). 2001, Vol 161, Num 3, pp 385-391, issn 0003-9926Article

Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute Myocardial InfarctionKLEIMAN, N. S; TRACY, R. P; TALLEY, J. D et al.Journal of thrombosis and thrombolysis. 2000, Vol 9, Num 1, pp 5-12, issn 0929-5305Article

AntithromboticsUPRICHARD, Andrew C. G; GALLAGHER, Kim P.Handbook of experimental pharmacology. 1999, Vol 132, issn 0171-2004, 504 p.Serial Issue

Functional characterization of PM6/13, a β3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human plateletsPATEL, Y; RAHMAN, S; SIDDIQUA, A et al.Thrombosis and haemostasis. 1998, Vol 79, Num 1, pp 177-185, issn 0340-6245Article

Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasmaTAY, Siow-Phing; CHEONG, Soon-Keng; BOO, Nem-Yun et al.Blood coagulation & fibrinolysis. 2003, Vol 14, Num 2, pp 125-129, issn 0957-5235, 5 p.Article

Regular article randomized comparison of platelet-leukocyte aggregates and platelet activation in blood: heparin-coated coiled wire stent implantation versus balloon angioplasty in acute myocardial infarctionJASTER, Markus; SCHWIMMBECK, Peter; SPENCKER, Sebastian et al.Thrombosis research. 2003, Vol 112, Num 5-6, pp 285-289, issn 0049-3848, 5 p.Article

Comparison of three methods for measuring PEG-hirudin in bloodHOFFMANN, J. J. M. L; JANSSEN, W. C. M.Blood coagulation & fibrinolysis. 2001, Vol 12, Num 7, pp 577-581, issn 0957-5235Conference Paper

Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca2+ mobilization without affecting inositol-1,4,5-trisphosphate (IP3) formation in activated plateletsRUOMEI QI; FULONG LIAO; INOUE, Katsue et al.Biochemical pharmacology. 2000, Vol 60, Num 10, pp 1475-1483, issn 0006-2952Article

YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclaseWU, C.-C; KUO, S.-C; LEE, F.-Y et al.European journal of pharmacology. 1999, Vol 381, Num 2-3, pp 185-191, issn 0014-2999Article

Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using High Performance Liquid Chromatography and functional methodsAHMAD, S; IQBAL, O; AHSAN, A et al.International angiology. 1999, Vol 18, Num 3, pp 198-205, issn 0392-9590Article

Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometerATTERMANN, J; KYNDE, K; HASENKAM, J. M et al.Thrombosis research. 1998, Vol 92, Num 6, pp 287-291, issn 0049-3848Article

Laboratory control of oral anticoagulant therapy : preservation of prothrombin time specimens using a polypropylene collection systemRIDYARD, J; BHAVNANI, M; SEAL, L. H et al.Clinical and laboratory haematology. 1998, Vol 20, Num 6, pp 369-372, issn 0141-9854Article

Effects of ATP, ADP, thrombin, vasopressin and U46619 on human placental nitric oxide synthase activityDI IULIO, J. L; GUDE, N. M; BRENNECKE, S. P et al.Methods and findings in experimental and clinical pharmacology. 1997, Vol 19, Num 8, pp 509-514, issn 0379-0355Article

C1qTNF-related protein-1 (CTRP-1) : a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen. CommentaryPOOLE, Alastair W; LASSER, Gerald; GUCHHAIT, Prasenjit et al.Blood. 2006, Vol 107, Num 2, issn 0006-4971, 10 p., 415-416,423-430 [10 p.]Article

The effect of 6-aminohexanoic acid and fucoidan on the activation of glutamic plasminogen by streptokinaseHARRIS, G; DOCTOR, V. M.Blood coagulation & fibrinolysis. 2002, Vol 13, Num 4, pp 355-359, issn 0957-5235Article

Differential expression of a Ligand Induced Binding Site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonistsJENNINGS, Lisa K; HAGA, Jason H; SLACK, Steven M et al.Thrombosis and haemostasis. 2000, Vol 84, Num 6, pp 1095-1102, issn 0340-6245Article

Monitoring antiplatelet therapy : What is the best method?MUKHERJEE, Debabrata; MOLITERNO, David J.Clinical pharmacokinetics. 2000, Vol 39, Num 6, pp 445-458, issn 0312-5963Article

Monitoring hypocoagulant conditions in rat plasma : Factors determining the endogenous thrombin potential of tissue factor-activated plasmaNIEUWENHUYS, Cécile M. A; FEIJGE, Marion A. H; BEGUIN, Suzette et al.Thrombosis and haemostasis. 2000, Vol 84, Num 6, pp 1045-1051, issn 0340-6245Article

Why is the standardization of prothrombin time a problem?TALSTAD, Ingebrigt.Haemostasis. 2000, Vol 30, Num 5, pp 258-267, issn 0301-0147Article

Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)JOHANNESSEN, M; NIELSEN, G; NORDFANG, O et al.Blood coagulation & fibrinolysis. 2000, Vol 11, pp S159-S164, issn 0957-5235, SUP1Conference Paper

Inhibitors of tissue factor/factor VIIaGALLAGHER, K. P; MERTZ, T. E; CHI, L et al.Handbook of experimental pharmacology. 1999, Vol 132, pp 421-445, issn 0171-2004Article

Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin) : Comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complexSHEU, J. R; KO, W. C; HUNG, W. C et al.Journal of pharmacy and pharmacology. 1997, Vol 49, Num 1, pp 78-84, issn 0022-3573Article

Therapeutic aspects of platelet pharmacologyCATELLA-LAWSON, F; FITZGERALD, G. A.Handbook of experimental pharmacology. 1997, Vol 126, pp 719-736, issn 0171-2004Article

Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisHARENBERG, J; STEHLE, G; BLAUTH, M et al.Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 1, pp 83-90, issn 0094-6176Conference Paper

  • Page / 1825